Guidelines for designing rapid assessment surveys of HIV seroprevalence among hospitalized patients. Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention has developed guidelines for determining HIV seroprevalence among patients seeking medical care at acute-care hospitals. The guidelines enable hospital staff members to perform a simple, rapid, and inexpensive survey to determine seroprevalence among the patient population, protecting the anonymity of those who are tested. The guidelines are based on national experience with large-scale anonymous, unlinked HIV serosurveys. The data from a rapid assessment survey are particularly useful for evaluating the need to provide routine, voluntary HIV counseling and testing and treatment for HIV infection. Beyond that, such data can be used in targeting education efforts, in reinforcing the use of appropriate universal precautions, in resource allocation, and in determining the need for further studies of HIV infection among the population in the hospital catchment area.
Schwartländer
B
B
Centers for Disease Control and Prevention, Atlanta, GA 30333.
Janssen
R S
RS
Satten
G A
GA
Critchley
S E
SE
Petersen
L R
LR
Dondero
T J
TJ
D015492:AIDS Serodiagnosis / Q000592:standards*; D005260:Female; D006679:HIV Seropositivity / Q000175:diagnosis; D015528:HIV Seroprevalence; D006761:Hospitals / Q000592:standards*; D006801:Humans; D008297:Male; D011159:Population Surveillance / Q000379:methods; D012308:Risk Management; D016036:Seroepidemiologic Studies; D014481:United States